Skip to main content
. 2018 Jun 5;8:189. doi: 10.3389/fcimb.2018.00189

Table 2.

List of the differentially expressed metabolites involved in amino acid metabolism during the acute and chronic phases of Toxoplasma gondii infection.

Metabolites FC q-value VIP CV Metabolic pathways
ACUTELY INFECTED VS. CONTROL
L-Thyroxine 0.23 4.73e-03 1.19 Tyrosine metabolism
3-Methoxy-4-hydroxyphenylacetaldehyde 0.51 2.83e-02 1.08
gamma-Glutamyl-gamma-aminobutyraldehyde 2.59 4.45e-03 1.80 Arginine and proline metabolism
Nopaline 1.84 6.92e-03 1.21
Indole-3-ethanol 2.17 5.45e-03 1.38 Tryptophan metabolism
Taurocholate 0.12 3.70e-02 1.20 Taurine and hypotaurine metabolism
Glutathionylspermidine 1.77 8.84e-03 1.21 Glutathione metabolism
Trypanothione disulfide 2.16 8.94e-03 1.15
Trypanothione 9.45 1.81e-03 3.28
CHRONICALLY INFECTED VS. CONTROL
L-Thyroxine 0.12 5.00e-04 1.71 Tyrosine metabolism
3-Methoxy-4-hydroxyphenylacetaldehyde 0.50 2.58e-02 1.19
L-Cystathionine 0.51 2.08e-02 1.21 Glycine, serine and threonine metabolism; Cysteine and methionine metabolism
N-Formyl-L-aspartate 0.65 3.73e-04 1.03 Histidine metabolism
Glutathionylspermidine 1.58 3.39e-02 1.01 Glutathione metabolism
Trypanothione disulfide 2.66 3.34e-03 1.56
Trypanothione 6.21 5.32e-03 2.95

FC, Fold change; q-value, adjusted p value calculated by the two-tailed Wilcoxon rank-sum tests after false discovery rate correction; VIP, variable importance in projection; CV, Content variance. A single arrow (↑/↓) indicates increased or decreased values compared to the control group.